GLP-1 drugs and their effects on bone and muscle health in midlife women
Part of Bones, joints & muscles, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at how GLP-1 medications (used for weight loss or diabetes) affect bone and muscle health in women aged 35 to 60. It aims to help understand if these drugs have any impact beyond weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 35 and 60 years old.
- Your body mass index (BMI) is 30 or higher, or at least 27 with a related health condition like high blood pressure or PCOS.
- You have just started or recently started a GLP-1 medication (like Ozempic, Wegovy, or similar).
- Your weight has been stable for the past 6 months (no big ups or downs).
- You speak and read English.
- You do not have type 2 diabetes, and you have not taken a GLP-1 drug in the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how GLP-1 receptor agonist medications (like liraglutide or semaglutide) affect bone health in adolescents and young adults with obesity. It aims to understand if these weight loss drugs have any impact on bone density and metabolism.
This study tests whether a 12-week program of exercise and personalized nutrition counseling can help obese adults maintain muscle and bone while taking GLP-1 medications (drugs that help with weight loss). GLP-1 drugs can sometimes cause muscle loss, so this trial explores whether targeted exercise and nutrition can prevent that.
This study looks at whether exercise can help prevent muscle loss in people taking GLP-1 medications (like Wegovy, Ozempic, or Mounjaro) for weight loss. It may help you keep your muscles strong while you lose weight.
This study looks at how a type of weight-loss medication called GLP-1 affects pregnancy and baby outcomes. It aims to learn if this medication is safe to use early in pregnancy.
This study tests whether a diabetes medication called a GLP-1 receptor agonist can help improve bone and muscle health in older women with type 2 diabetes who are at risk for osteoporosis. It aims to see if the drug can strengthen bones and prevent falls.
This study tests if eating extra protein helps middle-aged women with overweight or obesity who are just starting a GLP-1 medication. You would eat extra protein for a few weeks while staying active as usual.
Hear when a new Body Composition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.